[1]
R. Oladipupo, A. et al. 2019. Microbial Metabolites and Enzymes Inhibition in Drug Discovery and Development: A Case Study of the Statins, a Class of HMG-CoA Reductase Inhibitors: doi.org/10.26538/tjnpr/v3i4.1. Tropical Journal of Natural Product Research (TJNPR). 3, 4 (Apr. 2019), 99–106.